Clinical Trial Search

Primary: Percentage of Successful Task Completions — 100; 100; 100; 100 percentage of tasks

Primary: (PAI-1) Plasminogen Activator Inhibitor -1 Antigen — 4.59; 3.78; 13.59; 17.8 ng/ml — p=0.03

Primary: Change in the Number of Demodex Mites — -3; -0.4 Mites

Primary: Specificity — 71.4 percentage of true negatives

Primary: Percent of Women Who Develop Grade 3 or 4 Radiation Dermatitis (as Defined by the Stanford Radiation Dermatitis Scoring System) During a Course of Radiation Therapy — 6…

Primary: Skeletal Radiograph Evaluation Using a Qualitative Radiographic Global Impression of Change (RGI-C) Scale Compared to Baseline (Pre-treatment) in Study ENB-006-09…

Primary: Drug Use Status and Frequency — 2.00; 0.03; 0.02; 0.60 units on a scale

Primary: Tolerability of AC 170 0.24% at Visit 1 (Day 1) — 0.87; 0.50; 0.64; 0.42 units on a scale

Primary: Volume of Allogenic Blood Transfused Postoperatively — 458.33; 382.35 mL

Primary: Percentage of Capsular Tears (Anterior or Posterior) During Surgery — 5.3; 5.3 percentage of capsular tears

Primary: Number of Participants With Demonstrated Improvement From Baseline on the Hopkins Verbal Learning Test-Revised (HVLT-R) Total Recall — 20; 23 Participants

Primary: Proportion of Patients With PSA Response (pt) Within 12 Weeks of Samarium 153 Administration — 7 percentage of participants

Primary: Percentage of Subjects With ≥2-Grade Improvement From Baseline on Both the Investigator's and Subject's Facial Wrinkle Scale (FWS) Ratings of Forehead Line Severity at…

Primary: Flow-Mediated Dilation (FMD) — 3.1; 6.7; 4.7; 6.9 percentage of change in FMD — p=<0.05

Primary: Nausea — 44; 14; 22 Participants — p=< 0.00001